Ya-Li Sang

466 total citations
20 papers, 412 citations indexed

About

Ya-Li Sang is a scholar working on Infectious Diseases, Virology and Organic Chemistry. According to data from OpenAlex, Ya-Li Sang has authored 20 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Virology and 7 papers in Organic Chemistry. Recurrent topics in Ya-Li Sang's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Ya-Li Sang is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (11 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Ya-Li Sang collaborates with scholars based in China, Belgium and Czechia. Ya-Li Sang's co-authors include Erik De Clercq, Christophe Pannecouque, Fen‐Er Chen, Chunlin Zhuang, Sheng Han, Hai‐Liang Zhu, Yongtao Duan, Zhong‐Chang Wang, Pengfei Wang and Qing Wen and has published in prestigious journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Ya-Li Sang

20 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya-Li Sang China	14	226	187	142	121	95	20	412
Sanjeev Kumar V. Vernekar United States	13	271 1.2×	246 1.3×	235 1.7×	181 1.5×	53 0.6×	16	577
Cristina Gardelli Italy	14	287 1.3×	239 1.3×	202 1.4×	125 1.0×	84 0.9×	26	584
Ingrid Guse Canada	16	400 1.8×	144 0.8×	197 1.4×	102 0.8×	94 1.0×	20	594
Lanlan Jing China	13	325 1.4×	258 1.4×	221 1.6×	206 1.7×	103 1.1×	22	623
R W Buckheit United States	10	191 0.8×	221 1.2×	161 1.1×	204 1.7×	82 0.9×	14	502
Alessia Petrocchi Italy	11	138 0.6×	258 1.4×	298 2.1×	146 1.2×	92 1.0×	18	561
Vandna Munshi United States	13	227 1.0×	357 1.9×	208 1.5×	278 2.3×	105 1.1×	14	592
Sandrine Vendeville France	11	174 0.8×	144 0.8×	184 1.3×	47 0.4×	195 2.1×	15	519
Yves Bousquet Canada	13	258 1.1×	211 1.1×	195 1.4×	60 0.5×	113 1.2×	15	575
Karen R. Romines United States	14	440 1.9×	238 1.3×	158 1.1×	192 1.6×	95 1.0×	15	717

Countries citing papers authored by Ya-Li Sang

Since Specialization

Citations

This map shows the geographic impact of Ya-Li Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Li Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Li Sang more than expected).

Fields of papers citing papers by Ya-Li Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya-Li Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Li Sang. The network helps show where Ya-Li Sang may publish in the future.

Co-authorship network of co-authors of Ya-Li Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Ya-Li Sang. A scholar is included among the top collaborators of Ya-Li Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-Li Sang. Ya-Li Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sang, Ya-Li, Christophe Pannecouque, Erik De Clercq, Shuai Wang, & Fen‐Er Chen. (2023). Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability. Acta Pharmaceutica Sinica B. 13(7). 3054–3066. 10 indexed citations

Sang, Ya-Li, Christophe Pannecouque, Erik De Clercq, Shuai Wang, & Fen‐Er Chen. (2023). Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy. Journal of Medicinal Chemistry. 66(7). 4755–4767. 11 indexed citations

Sang, Ya-Li, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, & Fen‐Er Chen. (2021). Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity. Bioorganic Chemistry. 111. 104905–104905. 10 indexed citations

Sang, Ya-Li, Christophe Pannecouque, Erik De Clercq, Chunlin Zhuang, & Fen‐Er Chen. (2020). Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic Chemistry. 96. 103595–103595. 15 indexed citations

Sang, Ya-Li, Li Ding, Chunlin Zhuang, & Fen‐Er Chen. (2020). Design strategies for long-acting anti-HIV pharmaceuticals. Current Opinion in Pharmacology. 54. 158–165. 10 indexed citations

Sang, Ya-Li, Sheng Han, Erik De Clercq, et al.. (2019). Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains. European Journal of Medicinal Chemistry. 176. 11–20. 14 indexed citations

Han, Sheng, Ya-Li Sang, Yan Wu, et al.. (2019). Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 185. 111874–111874. 14 indexed citations

Sang, Ya-Li, Sheng Han, Shuwen Han, et al.. (2019). Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strains. Bioorganic Chemistry. 89. 102974–102974. 25 indexed citations

Sang, Ya-Li, Sheng Han, Christophe Pannecouque, et al.. (2019). Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 182. 111603–111603. 27 indexed citations

10.

Sang, Ya-Li, Sheng Han, Christophe Pannecouque, et al.. (2019). Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles. Journal of Medicinal Chemistry. 62(24). 11430–11436. 36 indexed citations

11.

Han, Sheng, Ya-Li Sang, Yan Wu, et al.. (2019). Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles. ACS Infectious Diseases. 6(5). 787–801. 35 indexed citations

12.

Sang, Ya-Li, et al.. (2018). Design and synthesis of a novel series of non-nucleoside HIV-1 inhibitors bearing pyrimidine and N-substituted aromatic piperazine. Bioorganic & Medicinal Chemistry Letters. 28(22). 3491–3495. 18 indexed citations

13.

Sang, Ya-Li, Weiming Zhang, Peng‐Cheng Lv, & Hai‐Liang Zhu. (2016). Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization. Current Topics in Medicinal Chemistry. 17(2). 120–137. 24 indexed citations

14.

Duan, Yongtao, Ya-Li Sang, Jigar A. Makawana, et al.. (2014). Discovery and molecular modeling of novel 1-indolyl acetate – 5-Nitroimidazole targeting tubulin polymerization as antiproliferative agents. European Journal of Medicinal Chemistry. 85. 341–351. 26 indexed citations

15.

Duan, Yongtao, Zhong‐Chang Wang, Ya-Li Sang, et al.. (2014). Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors. European Journal of Medicinal Chemistry. 76. 387–396. 18 indexed citations

16.

Duan, Yongtao, Yongfang Yao, Shashikant B. Teraiya, et al.. (2014). Synthesis and biological evaluation of quinoline–imidazole hybrids as potent telomerase inhibitors: a promising class of antitumor agents. RSC Advances. 4(39). 20382–20382. 20 indexed citations

17.

Sang, Ya-Li, Yongtao Duan, Han‐Yue Qiu, et al.. (2014). Design, synthesis, biological evaluation and molecular docking of novel metronidazole derivatives as selective and potent JAK3 inhibitors. RSC Advances. 4(32). 16694–16704. 11 indexed citations

18.

Wang, Zhong‐Chang, Yajuan Qin, Pengfei Wang, et al.. (2013). Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: Design, synthesis, inhibitory activity and 3D-QSAR analysis. European Journal of Medicinal Chemistry. 66. 1–11. 54 indexed citations

19.

Duan, Yongtao, et al.. (2013). Exploration of Structure-Based on Imidazole Core as Antibacterial Agents. Current Topics in Medicinal Chemistry. 13(24). 3118–3130. 21 indexed citations

20.

Wang, Zhong‐Chang, Yongtao Duan, Yajuan Qin, et al.. (2013). Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: Design, synthesis and biology analysis. European Journal of Medicinal Chemistry. 65. 456–463. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact